Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
ResMed Inc. - SIC # 3843 - DENTAL EQUIPMENT AND SUPPLIES
Ticker
Exchange
SIC #
Website
Latest Ticker
RMD
New York
3843
www.resmed.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for ResMed Inc.
ResMed (RMD): Buy, Sell, or Hold Post Q2 Earnings?
- Oct 5th, 2026 10:11 am
2 Cash-Producing Stocks with Promising Prospects and 1 We Brush Off
- Oct 2nd, 2026 3:42 am
Resmed to Report First Quarter Fiscal 2027 Earnings on October 29, 2026
- Oct 1st, 2026 2:05 pm
This Stock Could Be the Big Winner Out of Oura’s IPO
- Sep 28th, 2026 2:36 pm
Is ResMed A Better Way Than Stryker To Own Medical Device Growth?
- Sep 28th, 2026 10:49 am
ResMed Targets 12%-14% EPS Growth as GLP-1 Patients Lift Sleep Therapy Demand
- Sep 21st, 2026 2:02 pm
ResMed Inc. (RMD)’s Sleep Apnea Leadership Supports Growth Despite Rising Competitive Pressures
- Sep 19th, 2026 2:18 am
Sleep Device Maker ResMed Gets an Upgrade. Analysts See a Lot to Like.
- Sep 15th, 2026 2:07 pm
This Analyst Just Upgraded ResMed Stock. Here's Why.
- Sep 15th, 2026 1:57 pm
Is Margin Pressure From Rising Costs Altering The Investment Case For ResMed (RMD)?
- Sep 15th, 2026 11:11 am
ResMed Projected to Attain High-Single-Digit EPS Growth in Next Three Years, RBC Says
- Sep 15th, 2026 9:00 am
Is This the Right Time to Retain Resmed Stock in Your Portfolio?
- Sep 15th, 2026 8:10 am
Ulta Beauty, Etsy upgraded: Wall Street's top analyst calls
- Sep 15th, 2026 7:35 am
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Autodesk, Eli Lilly, Etsy, Lear, Netskope, Nokia, Northrop Grumman, Rapid7, Rivian Automotive, Ulta Beauty, and More
- Sep 15th, 2026 6:04 am
Patient Monitoring Stocks Q2 Teardown: ResMed (NYSE:RMD) Vs The Rest
- Sep 14th, 2026 1:15 pm
ResMed Stock: Is RMD Underperforming the Healthcare Sector?
- Sep 14th, 2026 7:07 am
Frazier Healthcare Partners Completes Acquisition of MatrixCare, Appoints Jonathan Lujan as Chief Executive Officer
- Sep 1st, 2026 6:30 am
2 Profitable Stocks Worth Investigating and 1 We Turn Down
- Sep 1st, 2026 5:30 am
Resmed Announces Participation in the 24th Annual Morgan Stanley Global Healthcare Conference
- Aug 27th, 2026 2:05 pm
2 S&P 500 Stocks with Promising Prospects and 1 We Ignore
- Aug 27th, 2026 10:01 am
Scroll